Find Your Study
Current Clinical Studies
Explore our active clinical trials and find opportunities to participate in advancing medical research.
Pegloticase in Kidney Transplant Patients with Uncontrolled Gout
A multicenter, open-label study evaluating the efficacy and safety of pegloticase (KRYSTEXXA) in adults with chronic gout refractory to conventional urate-lowering therapy who have undergone kidney transplantation. The primary endpoint is sustained serum uric acid reduction to <6 mg/dL during Month 6.
SNP-ACTH Gel for Primary Membranous Nephropathy
A Phase 3 superiority study comparing the safety and efficacy of SNP-ACTH (1-39) Gel versus rituximab in adults with high-risk primary membranous nephropathy. The study evaluates complete remission of proteinuria at 12 months with durability confirmation at 24 months.
Lorundrostat Open-Label Extension Study
An open-label extension evaluating long-term safety and blood pressure-lowering efficacy of lorundrostat, an aldosterone synthase inhibitor, in adults with uncontrolled hypertension who completed prior lorundrostat parent trials.
FINE-REAL: Finerenone in Routine Clinical Practice
A prospective, non-interventional study evaluating real-world treatment patterns, safety outcomes, and healthcare utilization in CKD patients with Type 2 Diabetes treated with finerenone, a novel non-steroidal mineralocorticoid receptor antagonist.